Since its function in 2007, General Bio has invested resources and efforts at developing natural and functional materials, new bio-materials from microorganisms, and biologically active substances of ...
Sub-Licensing AvailableDear Sir, Munogenics, Inc. develops, tests, and licenses novel biological methods for treating and preventing malignant diseases in humans. The company has a proprietary revolut...